Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities
Net income/(loss)	$ (9,331,746)	$ 711,100
Adjustments to reconcile net loss to net cash provided/(used) by operating activities:
Depreciation and amortization	862,683	680,004
Loss on disposal of property and equipment	30,558	9,219
Amortization of right-of-use assets	338,643	438,539
Change in allowance for doubtful accounts	(1,839)	(137,356)
Share-based compensation	72,417	65,318
Income tax expense/ (benefit)		127,431
Interest expense paid in equity shares	1,521,992	657,329
Accrued interest on notes payable	329,264	41,833
Amortization of original issue discounts on notes payable	583,333	475,000
Gain on marketable securities	(159,905)	(1,869,338)
Discharge of Paycheck Protection Program Loans	(971,500)
Settlement Agreement - Related Party		(3,674,165)
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:
Accounts receivable	1,807,167	1,420,861
Accounts receivable - related party	14,641	(71,581)
Inventory	(1,409,367)	(565,002)
Prepaid expenses and other current assets	(781,991)	(631,714)
Other assets	(83,146)	169,346
Other liabilities	(17,163)	11,438
Accounts payable	529,558	(543,272)
Operating lease liabilities	(246,715)	(450,102)
Deposits from customers	(352,086)	66,808
Accrued expenses	(311,539)	161,820
Deferred revenue	653,707	138,595
Income taxes payable	(312,806)	(88,765)
Net cash used by operating activities	(7,235,840)	(2,856,654)
Cash Flows from Investing Activities
Purchase of property and equipment	(935,499)	(944,601)
Proceeds from sale of property and equipment	230,901
Investment in MasterpieceVR	(500,000)	(500,000)
Investment in related party		(900,000)
Proceeds from sale of marketable securities	176,945	7,080,375
Purchase of marketable securities	(4,626,862)	(4,845,903)
Net cash used by investing activities	(5,654,515)	(110,129)
Cash Flows from Financing Activities
Proceeds from notes payable	8,000,000
Payments on notes payable	(901,763)	(2,070,257)
Payments on bank loans	(613,900)	(655,276)
Proceeds from Paycheck Protection Program Loans		1,970,785
Net cash provided/(used) by financing activities	6,484,337	(754,748)
Effect of currency translation	(150,076)	(70,668)
Net decrease in cash, cash equivalents, and restricted cash	(6,406,018)	(3,721,531)
Cash, cash equivalents, and restricted cash at beginning of period	17,186,323	21,072,859
Cash, cash equivalents, and restricted cash at end of period	10,630,229	17,280,660
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash
Cash and equivalents	8,970,324	15,573,734
Restricted cash	1,659,905	1,706,926
Total cash, cash equivalents, and restricted cash	10,630,229	17,280,660
Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for interest	288,397	283,855
Cash paid during the period for income taxes	312,806	88,765
Supplemental Schedule of Non-Cash Investing and Financing Activities
Investment in Virtual Driver Interactive		439,774
Stock issued to pay notes payable	3,288,071	1,707,327
Shares issued in connection with note payable	700,400
Financing of right of use assets	$ 317,187